Listed by the USPTO as HOERNER, PAUL ELLSWORTH
Tech Center 3700 • Art Units: 1611 1645 3774
This examiner grants 51% of resolved cases
Paul Ellsworth Hoerner works in Tech Center 3700 and Art Unit 1611. He has 83 resolved cases and an allowance rate of 50.6%. The median time to allowance is 1341 days. The interview lift is 62.3%, which is a very high increase over the baseline allowance rate.
Mind Medicine Inc., L'Oréal, and SUMITOMO CHEMICAL Company, Limited are top applicants. COOLEY LLP, OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., and pH IP Law are the leading firms. The 50.6% allowance rate suggests a moderate level of difficulty, but the 62.3% interview lift indicates that direct communication is exceptionally effective. The 1341 days median pendency is a key factor for applicants to consider. With 83 resolved cases, the examiner has a developing record in chemical and pharmaceutical technology.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17600843 | LIPID NANOPARTICLES AS ORAL VEHICLES OF IMMUNOTHERAPY | Final Rejection | The Johns Hopkins University |
| 18847255 | PEROXIDE HYDROGEL COMPOSITIONS AND THEIR USE FOR FIBER BLEACHING | Non-Final OA | HENKEL AG & CO. KGAA |
| 18719164 | METHODS FOR DESIGNING AND PERFORMING A VAPOR PHASE HYDROGEN PEROXIDE DECONTAMINATION CYCLE | Final Rejection | Amgen Inc. |
| 17819268 | DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18827288 | SPHERICAL AGGLOMERATION OF PROTEINS | Non-Final OA | Purdue Research Foundation |
| 18723132 | IRON OXIDE NANOPARTICLE-MEDIATED RADIATION DELIVERY FOR TARGETED CANCER TREATMENT | Non-Final OA | University of Washington |
| 18257983 | COSMETIC COMPOSITION COMPRISING A COMBINATION OF TWO PARTICULAR COUPLERS AND A NONIONIC SURFACTANT OF ALKYLPOLYGLYCOSIDE TYPE | Final Rejection | L'OREAL |
| 17311260 | TOPICAL COMPOSITION COMPRISING VIABLE MICROORGANISMS | Final Rejection | L'Oreal S.A. |
| 18715218 | Personal Care Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18987772 | WEED CONTROL METHOD | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18255000 | PESTICIDAL COMPOSITION | Final Rejection | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 17434299 | MICROWAVE ASSISTED EXTRACTION OF ESSENTIAL OILS FROM PLANT BIOMASS | Non-Final OA | FIRMENICH SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy50.6% of resolved applications examined by Paul Ellsworth Hoerner were allowed (83 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +62.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Paul Ellsworth Hoerner took 1,341 days on average from filing to allowance.
Paul Ellsworth Hoerner examines applications in Art Unit 1611 in Tech Center 3700 (Medical Devices & Mechanical Engineering).